The imbalance in CSF T cell subsets in active multiple sclerosis

Acta Neurologica Scandinavica

Volumn 77, Issue 3, 1988, Pages 202-209

  Matsui, M ^a   Mori, K J ^a   Saida, T ^b   Akiguchi, I ^a   Kameyama, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

cerebrospinal fluid; flow cytometry; multiple sclerosis; T cell subsets

Indexed keywords

MEMBRANE ANTIGEN;

CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTOLOGY; DEMYELINATION; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; BRAIN DISEASES; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0023897202     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1988.tb05895.x     Document Type: Article

References (43)

1. Multiple sclerosis
2. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity
3. Multiple sclerosis: relation of in vitro IgG secretion to T suppressor cell number and function
4. Comparison of T8+ cell‐mediated suppressor and cytotoxic functions in multiple sclerosis
5. Loss of suppressor T cells in active multiple sclerosis: analysis with monoclonal antibodies
6. Immunoregulatory T‐cell and lymphocyte toxic antibodies in active multiple sclerosis: weekly analysis over a six‐month period
7. A serial study of peripheral blood T lymphocyte subsets in relapsing‐remitting multiple sclerosis
8. Disease activity markers in multiple sclerosis: another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8
9. Altered blood T‐cell subsets in patients with multiple sclerosis
10. T cell subsets in multiple sclerosis: a longitudinal study of exacerbating‐remitting cases
11. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis
12. Multiple sclerosis: distribution of T cells, T cell subsets and la‐positive macrophages in lesions of different ages
13. Further lymphocyte characterization in the central nervous system in multiple sclerosis
14. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
15. In vitro cell‐mediated immunity of cerebrospinal‐fluid lymphocytes to myelin basic protein in primary demyelinating diseases
16. Analysis of T regulator cell surface markers and functional properties in multiple sclerosis
17. Monoclonal antibody‐defined immunoregulatory cells in multiple sclerosis
18. CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T‐cell subsets
19. Lymphocyte populations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis
20. Characterization of cerebrospinal fluid lymphocytes in multiple sclerosis
21. Unsuspected multiple sclerosis
22. Criteria for the clinical diagnosis of multiple sclerosis
23. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
24. A unique human B lymphocyte antigen defined by a monoclonal antibody
25. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK‐1)
26. Prednisone‐induced alterations of circulating human lymphocyte subsets
27. The cerebrospinal fluid in multiple sclerosis
28. Indicators of disease activity in multiple sclerosis: studies of myelin basic proteinlike materials
29. Megnetic resonance imaging: serial observations in multiple sclerosis
30. Multiple sclerosis: MRI and clinical correlation
31. Circulating immune complexes in multiple sclerosis: relation with disease activity
32. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions
33. Quantitative cerebrospinal fluid IgG measurements as a marker of disease activity in multiple sclerosis
34. CSF neopterin as marker of disease activity in multiple sclerosis
35. Immunity and the blood‐brain barrier
36. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cell recognize products of different major histocom‐patibility complex regions
37. On the presence of Ia‐positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation
38. Endothelial cell presentation of antigen to human T cells
39. Astrocytes present myelin basic protein to encephalitogenic T‐cell lines
40. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens
41. Detection of in vivo stimulated cerebrospinal‐fluid lymphocytes by flow cytometry in patients with multiple sclerosis
42. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
43. Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations